Parasites clue to why allergies are more common in developed countries

February 16, 2017 by Emma Rayner, University of Nottingham
Parasites clue to why allergies are more common in developed countries
Credit: University of Nottingham

A molecular mechanism which could explain why allergies are more common in developed countries has been discovered by researchers at The University of Nottingham.

The experts in parasitology from the School of Life Sciences report in the journal Immunology that this finding could lead to new immunotherapies to prevent allergies.

Allergies are known to be much more prevalent in Western populations but up to now why this is the case has been a mystery. One popular theory is the hygiene hypothesis, which suggests that our immune systems need to come into contact with a range of micro-organisms at a young age to produce appropriate immune responses later in life.

"Allergies are a type of inappropriate immune , where our bodies misidentify a harmless substance as a threat," said study author Dr Joseph Igetei who carried out the research at Nottingham.

"We know that parasitic worm infections occur more frequently in less developed countries, in places where allergies are rare.  Although it's been suggested that worm infections could prevent allergy, there has been little concrete evidence of the potential molecular mechanisms that might mediate any such relationship."

The research team led by Professor Mike Doenhoff from The University of Nottingham, and including Dr Marwa El-Faham from Alexandria University and Dr Susan Liddell set out to discover if the antigens produced by a common species of parasitic worm that infects humans (called Schistosoma mansoni) were cross-reactive to antigens from peanuts, i.e. do the proteins from the worm and from the peanuts trigger the same immune response? 

Antibodies are a type of immune protein made by the body to provide a tailored response to any substance deemed to be a threat so the team used antibodies from rabbits that had been exposed to various life stages of the worm. The researchers tested if these antibodies (which had been produced specifically against the ) also reacted to various proteins found in peanuts.

They found that the antibodies responded to several proteins in the peanut, in particular one called Ara h 1, which is known to be a key player in inducing the negative response in people who are allergic to peanuts.

Co-author Professor Michael Doenhoff said: "It may sound strange that peanuts and worms have anything in common that could cause the to generate the same response. However, our work indicates that proteins from these two seemingly very different organisms actually have identical markers on them, meaning the immune system views them in the same way and targets them with the same antibody."

The findings are important in two ways.  Firstly, this work goes some way to explaining the behind the observation that countries with a high incidence of have a low incidence of .  Although more work is needed to confirm the exact relationship, the team think that antibodies produced in response to a worm infection could stop the immune system from producing an allergic reaction when faced with a novel substance such as peanut protein.  Secondly, this work opens up new therapeutic avenues to explore to treat allergies using immunotherapy.  The team's next step is to see if antibodies produced by humans in response to a worm infection also cross-react with peanut proteins.

Explore further: Dry roasting could help trigger peanut allergy

Related Stories

Dry roasting could help trigger peanut allergy

September 21, 2014
Dry roasted peanuts are more likely to trigger an allergy to peanuts than raw peanuts, suggests an Oxford University study involving mice.

Allergy is the price we pay for our immunity to parasites

October 29, 2015
New findings, published in PLOS Computational Biology, help demonstrate the evolutionary basis for allergy. Molecular similarities in food and environmental proteins that cause allergy (such as pollen), and multicellular ...

Understanding the body's response to worms and allergies

April 24, 2015
Research from The University of Manchester is bringing scientists a step closer to developing new therapies for controlling the body's response to allergies and parasitic worm infections.

UWA Nobel Laureate develops drug to prevent food allergies

November 24, 2016
A new drug which "fine tunes" the immune system is being developed to help prevent asthma and allergies to foods such as peanuts and shellfish.

Hitherto unknown risk factor for arteriosclerosis identified

January 9, 2017
Following a blood infection, the first class of antibodies produced by the immune system are IgM antibodies. They form the "vanguard" of the immune response before other cells are activated to fight the infection. Some people ...

Skin exposure may contribute to early risk for food allergies

October 8, 2014
Many children may become allergic to peanuts before they first eat them, and skin exposure may be contribute to early sensitization, according to a study in mice led by Mount Sinai researchers and published today in the Journal ...

Recommended for you

How protein fragments could help to tackle the cause of hay fever

July 16, 2018
Imperial researchers are looking to protein fragments to help people build up resistance to grass pollen.

Team explores diabetes drug's ability to treat RSV infection

July 13, 2018
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis—inflammation and obstruction of the lungs' small airways. A multi-disciplinary team of Vanderbilt investigators ...

Testing suggests TORC1 inhibitors can boost immune system in the elderly

July 12, 2018
A team of researchers affiliated with Novartis Institutes for Biomedical Research and Biometrics Matters Limited, has found via testing with volunteers that TORC1 inhibitors can boost the immune system in the elderly. In ...

Biologists discover process that neutralizes tumors

July 10, 2018
Researchers from the University of California San Diego have identified an unexpected mechanism that could help determine whether a cancer patient will respond to immunotherapy.

Mitochondrial DNA in exosomes is the alarm that initiates the antiviral response

July 10, 2018
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have provided valuable information about the defense mechanisms of the immune system during the early stages of the response to pathogens ...

Antibody identifier could speed development of therapies for cancer, other diseases

July 10, 2018
A research team led by a UCLA bioengineer has developed a model to predict the extent to which new laboratory-designed antibodies will be able to combat specific human diseases. This is the first time that a comprehensive ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.